
DELRAY BEACH, Fla., Oct. 6, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Laboratory Software Market is projected to reach USD 10.62 billion by 2031 from USD 6.46 billion in 2026, at a CAGR of 10.5% during the forecast period.
Browse 250 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on 'Laboratory Software Market - Global Forecast to 2031'
Laboratory Software Market Size & Forecast:
- Market Size Available for Years: 2026–2031
- 2026 Market Size: USD 6.46 billion
- 2031 Projected Market Size: USD 10.62 billion
- CAGR (2026–2031): 10.5%
Laboratory Software Market Trends & Insights:
- North America dominates the market, with a share of 39.4% of the global laboratory software market in 2025.
- In 2025, the services segment held the largest share of 39.1% of the laboratory software market.
- AI-enabled lab software is projected to register the highest CAGR of 19.3% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203037633
The adoption of laboratory software is primarily driven by the growing need for data integrity, traceability, laboratory automation, and integrated management of increasingly complex laboratory workflows. LIMS, ELN, LES, CDS, and other laboratory informatics solutions enable centralized data management, audit trails, workflow automation, instrument integration, and controlled access to laboratory records, supporting operational efficiency and regulatory compliance. The growing emphasis on regulatory requirements and data integrity in pharmaceutical, biotechnology, clinical, and testing laboratories is further driving adoption, as regulatory inspections continue to identify deficiencies in laboratory records, electronic data controls, and audit trails. In addition, the laboratory software sector is transforming as cloud-based platforms, integrated laboratory informatics, automation, advanced analytics, and AI-enabled capabilities gain adoption. However, implementing and maintaining laboratory software can require significant investment in system configuration, integration, validation, training, maintenance, and specialized expertise, which can constrain adoption among laboratories with limited resources.
'AI-enabled laboratory software is expected to witness the fastest growth in the laboratory software market by technology maturity.'
Based on technology maturity, the laboratory software market is segmented into AI-enabled laboratory software and non-AI-enabled/conventional laboratory software. AI-enabled laboratory software is expected to register the fastest growth during the forecast period, driven by increasing demand for intelligent automation, advanced analytics, predictive insights, and improved laboratory decision-making. AI capabilities are increasingly being incorporated into laboratory workflows to support data interpretation, anomaly detection, workflow optimization, predictive quality control, and automated data analysis. The growing volume and complexity of laboratory data, along with the increasing adoption of digital and connected laboratory environments, is further driving demand for AI-enabled solutions. In addition, advances in machine learning, generative AI, and agentic AI are enabling laboratory software providers to introduce more intelligent, automated capabilities, supporting the transition to data-driven laboratory operations.
'The services segment held the largest share in the laboratory software market by component.'
Based on component, the laboratory software market is segmented into software, services, and support. The services segment accounted for the largest share of the laboratory software market in 2025, supported by the increasing need for implementation, configuration, integration, validation, training, maintenance, and technical support associated with laboratory software deployments. Laboratories often require specialized services to integrate LIMS, ELN, LES, CDS, and other informatics applications with laboratory instruments, enterprise systems, and existing data infrastructure. The growing complexity of laboratory workflows, increasing regulatory and data-integrity requirements, and the need for system validation and compliance are further driving demand for laboratory software services. In addition, the transition toward cloud-based and SaaS laboratory platforms is creating demand for migration, integration, customization, and ongoing managed services. The software segment also continues to expand as laboratories adopt LIMS, ELN, LES, SDMS, CDS, and other digital applications to automate workflows, manage laboratory data, improve interoperability, and enhance operational efficiency.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=203037633
'Asia Pacific is projected to witness the highest growth rate during the forecast period.'
The laboratory software market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is anticipated to experience the highest growth rate during the forecast period, supported by increasing technology adoption and rising investments across the region. The growing presence of universities, research institutions, and scientific centers is driving research and technological development, while greater investment by international pharmaceutical and biotechnology companies is strengthening regional laboratory infrastructure. In addition, increasing investments from European and North American life sciences companies in Asian markets are expected to encourage the adoption of Laboratory Software solutions across laboratories in the region.
Key Players
Leading players in the Laboratory Software companies include Thermo Fisher Scientific Inc. (US), LabVantage Solutions Inc. (US), LabWare (US), STARLIMS Corporation (US), Agilent Technologies Inc. (US), Waters Corporation (US), LabLynx, Inc. (US), Dassault Systèmes (France), Revvity (US), and Confience (US).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=203037633
Laboratory Software Market - Investment & funding +Merger & Acquisition
Investment And Funding Context
The laboratory software market continues to attract investment as laboratory operators and technology providers focus on automation, cloud-based platforms, AI-enabled informatics, data integration, and the digital transformation of laboratory workflows. Investment activity is increasingly centered on technologies that connect laboratory instruments, workflows, scientific data, and users while improving operational efficiency and scalability. Leading laboratory software providers are expanding their capabilities through product development, strategic partnerships, and investments in AI and automation. For example, LabVantage Solutions Inc. launched LabVantage CORTEX in March 2026, extending its LIMS platform with agentic AI, analytics, and cloud-native automation for laboratory operations. Similarly, Benchling has strengthened its AI capabilities through acquisitions and investments in AI-driven scientific workflows, including its acquisition of ReSync Bio and Sphinx Bio teams. These developments indicate increasing investment in AI-enabled, cloud-native, and integrated laboratory software capabilities.
Revenue Shift Context
The laboratory software market is gradually shifting from standalone, predominantly on-premise laboratory applications to integrated, cloud-based, subscription-oriented, and AI-enabled platforms that connect laboratory data, instruments, workflows, and enterprise systems. The global laboratory software market is projected to increase from USD 6.46 billion in 2026 to USD 10.62 billion by 2031, at a CAGR of 10.5%, with growth increasingly supported by laboratory automation, advanced analytics, and AI-enabled functionality. The growing need to manage larger volumes of laboratory data while improving interoperability, workflow efficiency, and regulatory compliance is creating opportunities for vendors offering connected and intelligent laboratory software platforms.
Mergers and Acquisitions
M&A activity in the laboratory software market during 2025–2026 has increasingly focused on expanding LIMS, ELN, laboratory informatics, scientific data management, AI, and manufacturing-quality capabilities, rather than purely consolidating traditional laboratory software providers. Recent transactions demonstrate a broader trend toward building integrated platforms that connect laboratory data, workflows, quality processes, and manufacturing operations.
LABORATORY SOFTWARE MARKET: MERGERS AND ACQUISITIONS, JANUARY 2025–JUNE 2026
Month & Year |
Deal Type |
Company 1 |
Company 2 |
Description |
May 2026 |
Acquisition |
STARLIMS Corporation (US) |
MODA Platform Lonza (Switzerland) |
STARLIMS completed the acquisition of the MODA Platform from Lonza, expanding its laboratory informatics portfolio into manufacturing execution, quality control, and digital production workflows. The acquisition enables STARLIMS to connect laboratory operations, quality management, and manufacturing processes within an integrated platform for regulated industries. |
January 2026 |
Acquisition |
Revvity (US) |
ACD/Labs (Canada) |
Revvity completed the acquisition of ACD/Labs, a provider of scientific software for analytical characterization and molecular design. The acquisition adds analytical data management, spectral analysis, molecular design, and AI-driven molecular property and ADMET prediction capabilities to Revvity's informatics portfolio. |
July 2025 |
Acquisition |
Clinisys, Inc. (UK) |
Orchard Software (US) |
Clinisys acquired Orchard Software from Francisco Partners, combining Orchard's laboratory information systems with Clinisys' laboratory informatics portfolio. The transaction strengthened Clinisys' capabilities across healthcare, life sciences, public health, and diagnostic laboratory environments. |
July 2025 |
Acquisition |
Instem (UK) |
Xybion Digital (US) |
Instem completed the acquisition of Xybion Digital, adding the Pristima preclinical study-management platform and expanding its capabilities in preclinical research and life sciences R&D |
July 2025 |
Acquisition |
Instem (UK) |
RockStep Solutions Inc (US) |
Instem completed the acquisition of RockStep Solutions Inc, provider of Climb, a cloud-based software solution for non-GLP preclinical study management. The acquisition expanded Instem's preclinical software portfolio by combining Climb with its Provantis GLP study-management platform and adding capabilities across study design, animal management, PK/PD analysis, pathology, and data visualization. |
Company Revenue Share Details
The laboratory software market is competitive, with leading providers holding meaningful positions while a broad group of established and specialized vendors competes across LIMS, ELN, LES, CDS, SDMS, laboratory quality, and other informatics applications. Thermo Fisher Scientific, Inc., LabWare, LabVantage Solutions Inc., STARLIMS Corporation, and Agilent Technologies, Inc. are among the leading players, supported by broad laboratory software portfolios, established customer bases, global presence, and continued investments in automation, cloud-based platforms, interoperability, and AI-enabled capabilities. The remaining market is distributed among companies such as Waters Corporation, Dassault Systèmes, LabLynx Inc., Revvity, Confience, Labworks, IDBS, Instem, Novatek International Inc., Agaram Technologies Pvt Ltd, Siemens, Caliber Technologies, Clinisys Inc., LabTrack, LabKey and Benchling which compete through specialized laboratory applications, cloud-native platforms, integrated informatics suites, and industry-specific solutions. The presence of both large, diversified technology companies and specialized laboratory software providers reflects the market's competitive nature and creates opportunities for product innovation, strategic partnerships, AI integration, cloud adoption, interoperability, and expanded integrated laboratory informatics capabilities.
Browse Adjacent Market: Healthcare IT Market Research Reports &Consulting
See More Latest Healthcare IT Reports:
Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, Workcell, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, HTS), End User (Pharma, Forensic, Environmental, Diagnostic Lab) - Global Forecast to 2031
Laboratory Information Management System Market by Type (Industry), Component (Software, Services), Deployment [On-premise, Cloud (SaaS, PaaS, IaaS)], Company Size (Mid-sized), Industry (Pharma, NGS, Chemicals, Agri, FnB, Oil), & Region - Global Forecast to 2031
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/lab-informatic-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/lab-informatic.asp
SOURCE MarketsandMarkets
Share this article